查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球慢性血液透析導管市場 - 2023-2030
市場調查報告書
商品編碼
1374768

全球慢性血液透析導管市場 - 2023-2030

Global Chronic Hemodialysis Catheter Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

多年來，全球慢性血液透析導管市場經歷了顯著的成長和轉變，影響其動態的因素有很多。 HDC（血液透析導管）是腎臟替代療法的重要組成部分。這些導管僅被視為安裝更永久的血管通路（如動靜脈瘺或移植物）之前的暫時解決方案。

政府投資和研究，特別是在發展中經濟體，將繼續推動先進技術的利用，並推動全球慢性血液透析導管市場的發展。各自的創新設備包括使用矽膠或聚氨酯等新型材料來實現更好的治療。

市場動態：促進因素

主要參與者越來越多收購血液透析導管

在高收入水準、投資和基礎設施發展的推動下，已開發經濟體的醫療保健產業不斷改善。由於其積極的研究成果，一些國家對慢性血液透析導管的需求量很大。主要參與者之間的各種收購和產品發布將是推動市場成長的關鍵因素。

2023 年 6 月 8 日，國際公認的醫療保健技術製造商和分銷商 Merit Medical Systems, Inc. 收購了 AngioDynamics, Inc. 的透析導管設備和活體組織切片道密封劑技術 BioSentry 組合，總現金估值1億美元。

根據《國際臨床實務期刊2022》通報，皖南醫學院與弋磯山醫院共同進行的研究結果顯示，隧道式套囊導管（TCC）的平均存活時間超過兩年。無論年齡、性別或原發疾病如何，我們發現TCC對於血管狀況不佳或生存時間短的維持性血液透析（MHD）患者來說是一種有效的選擇，或者作為等待內瘺生長的橋樑。

此外，擴大利用新技術或設備進行透析管理。人們意識的提高和創新設備開發研究的增加將是推動慢性血液透析導管市場成長的主要因素。

市場動態：限制

與導管相關的併發症

臨床結果不佳的部分原因可能是長期埋設的血液透析導管造成的。血液透析導管的主要問題是感染、中心靜脈狹窄和阻塞以及血栓和纖維蛋白鞘導致的功能不良。血栓形成或纖維蛋白鞘可能會導致血液透析不充分，因為它們會損害血流，特別是減少通過動脈腔的血流。

短期困難可能是由手術本身引起的，例如提供者缺乏經驗、進入部位、放置技術、患者疾病的嚴重程度以及伴隨條件。 HDC 的長期影響包括機械功能障礙、血栓形成、中心靜脈狹窄和導管相關血流感染 (CRBSI)。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按類型分類
  • Tip Design 的片段
  • 塗層片段
  • 最終使用者的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 主要參與者越來越多收購血液透析導管
      • 不斷進步的技術進步與發展
    • 限制
      • 與導管相關的併發症
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 定價分析
  • SWOT分析
  • 專利分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按類型

  • 帶套囊隧道導管
  • 無套囊隧道導管
  • 非隧道導管

第 8 章：透過尖端設計

  • 階梯提示
  • 分離尖頭
  • 對稱尖頭
  • 自定心尖端
  • Y 型尖端

第 9 章：透過塗層

  • 肝素塗層導管
  • 聚氨酯塗料
  • 抗生素塗層
  • 其他

第 10 章：最終用戶

  • 醫院
  • 專科診所
  • 其他

第 11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Teleflex Incorporated
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Medtronic
  • BD
  • AngioDynamics
  • Medical Components, Inc.
  • Merit Medical Systems
  • Fresenius Medical Care AG & Co. KGaA
  • Haolang Technology (Foshan) Limited Co., Ltd.
  • SCW Medicath Ltd
  • Vygon

第 14 章：附錄

簡介目錄
Product Code: MD7161

Overview

The global chronic hemodialysis catheter market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. HDCs (hemodialysis catheters) are a crucial component of kidney replacement therapy. These catheters are only seen as a temporary solution before installing more permanent vascular access, like arteriovenous fistulas or grafts.

Government investments and research, particularly in developing economies, will continue to drive utilization of advanced technologies and boost the global chronic hemodialysis catheter market. The respective innovative devices includes the use of novel materials such as silicone or polyurethane for better treatment.

Market Dynamics: Drivers

Growing acquisitions of hemodialysis catheters among key players

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high income levels, investments and infrastructure development. Several countries have experienced substantial demand for chronic hemodialysis catheter owing to its positive outcomes in research. Various acquisitions and product launches among key players will be a crucial factor driving the growth of the market.

On June 8, 2023, a portfolio of dialysis catheter devices and the Biopsy Tract Sealant Technology, BioSentry from AngioDynamics, Inc. have been acquired by Merit Medical Systems, Inc., an internationally recognized manufacturer and distributor of healthcare technology, for a total cash valuation of $100 million.

According to International Journal of Clinical Practices 2022, the results of the study conducted by Wannan Medical College associated with Yijishan Hospital show that the average Tunneled Cuffed Catheters (TCC) survive longer than two years. Regardless of age, sex, or primary condition, we discovered that TCC is an effective option for patients with Maintenance Hemodialysis (MHD) with poor vascular status or short survival time, or as a bridge while waiting for an internal fistula to grow.

Furthermore, the rising utilization of novel technologies or devices for the management of dialysis. Rising awareness among people and increasing research for innovative device development will be a major factor driving the growth of the chronic hemodialysis catheters market.

Market Dynamics: Restraints

Complications associated with the catheter

Poor clinical results may be caused in part by hemodialysis catheters that have been chronically tunneled. The main issues with hemodialysis catheters involve infection, central vein stenosis and blockage, and poor function brought on by thrombosis and fibrin sheath. Inadequate hemodialysis can result from thrombosis or fibrin sheath because they impair blood flow, especially by reducing inflow via the arterial lumen.

Short-term difficulties can be caused by the procedure itself, such as the inexperience of the provider, the site of access, the placement technique, the severity of the patient's disease, and concomitant conditions. The long-term effects of HDC include mechanical dysfunction, thrombosis, central venous stenosis, and catheter-related bloodstream infection (CRBSI).

Segment Analysis

The global chronic hemodialysis catheter market is segmented based on type, tip design, coating, end user and region.

Cuffed Tunneled Catheter segment holds approximately 41% of market share

Prior to the development or maturity of a long-term dialysis availability, such as an arteriovenous fistula (AVF) and arteriovenous grafty (AVG), tunneled catheters are utilized to provide vascular access. They are also utilized by patients who have used every available entry point for long-term access to dialysis. To reduce catheter disintegration, vascular harm, and catheter-related problems, tunneled catheters are composed of flexible materials like silicone or polyurethane-polycarbonate copolymer.

In general, polyurethane-polycarbonate copolymers are biocompatible. Tunneled cuffed catheters had been subsequently created, and the cuff's goal is to build a fibrous tissue that may act as a barrier preventing infection. Furthermore, by limiting displacement, the cuff and the related fibrous tissue may also offer a more stable access.

According to Indian Journal of Radiology and Imaging article 2023, tunneled lines are linked to greater long-term results, but the insertion procedure is more difficult and intrusive. In patients expected to need HD for longer than 2 to 3 weeks, cuffed TDCs are thus preferred over non-tunneled catheters, unless the situation is urgent and speedy access is required. The majority of qualified applicants for a TDC have a history of documented chronic kidney disease (CKD).

Geographical Penetration

North America accounted for around 33% of market share in 2022

Due to the rising need for chronic hemodialysis catheter in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for chronic hemodialysis catheter.

Increasing expenditure on healthcare and rising research studies, advancement of technologies and different type of devices for management, and increase in pharmaceutical or medical device business establishment across the region are also contributing to the growth of chronic hemodialysis catheter market share of this region. The market in this area is growing as people become more aware of various novel innovative products such as tunneled catheters. The aforementioned elements further attest to North America's hegemonic position in the world.

North America continues to be a key player in the global chronic hemodialysis catheter market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for chronic hemodialysis catheter in the U.S. United States have been proactive in executing several initiatives or researches, stimulating chronic hemodialysis catheter demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global chronic hemodialysis catheter market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020.

Major medical device industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for chronic hemodialysis catheter. Now several research studies have been initiated and companies have again started trial for their products safety and efficacy. Overall, the impact of the pandemic on the global chronic hemodialysis catheter market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for antimicrobial coated, self-cenetered catheter and other programs for management of renal kidney disease.

Key Developments

  • On August 21, 2023, the Arrow ErgoPack Comprehensive Kits with Hemodialysis plus Large Bore Catheters have been made available in the United States, according to Teleflex Incorporated, a top global manufacturer of medical technologies. The goal of this upgrade is to give clinicians more alternatives and streamline their insertion routine. With a selection of French diameters, lumens, and lengths, this extended kit configuration gives clinicians the option of using either Arrowg + ard Blue Hemodialysis and Large Bore lines.
  • On April 14, 2021, the U.S. Food and Drug Administration (FDA) granted 510(k) approval to BD (Becton, Dickinson and business), a preeminent worldwide medical technology business, for the Pristine a long-term Hemodialysis Catheter, a brand-new hemodialysis catheter with a distinctive symmetric Y-Tip side-hole free distal lumen design.

Competitive Landscape

The major global players in the market include: Teleflex Incorporated, Medtronic, BD, AngioDynamics, Medical Components, Inc., Merit Medical Systems, Fresenius Medical Care AG & Co. KGaA, Haolang Technology (Foshan) Limited Co., Ltd., SCW Medicath Ltd and Vygon.

Why Purchase the Report?

  • To visualize the global chronic hemodialysis catheter market segmentation based on type, tip design, coating, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of chronic hemodialysis catheter market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global chronic hemodialysis catheter market report would provide approximately 69 tables, 69 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Tip Design
  • 3.3. Snippet by Coating
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing acquisitions of hemodialysis catheters among key players
      • 4.1.1.2. Rising technological advancements and developments
    • 4.1.2. Restraints
      • 4.1.2.1. Complications associated with the catheter
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pricing Analysis
  • 5.6. SWOT Analysis
  • 5.7. Patent Analysis
  • 5.8. Russia-Ukraine War Impact Analysis
  • 5.9. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Cuffed Tunneled Catheter*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-cuffed Tunneled Catheter
  • 7.4. Non-tunneled Catheter

8. By Tip Design

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 8.1.2. Market Attractiveness Index, By Tip Design
  • 8.2. Step-Tip*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Split-Tip
  • 8.4. Symmetrical-Tip
  • 8.5. Self-centering Tip
  • 8.6. Y-Tip

9. By Coating

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 9.1.2. Market Attractiveness Index, By Coating
  • 9.2. Heparin-coated Catheters *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Polyurethane Coating
  • 9.4. Antibiotic Coating
  • 9.5. Other

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Specialty Clinics
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Teleflex Incorporated*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Medtronic
  • 13.3. BD
  • 13.4. AngioDynamics
  • 13.5. Medical Components, Inc.
  • 13.6. Merit Medical Systems
  • 13.7. Fresenius Medical Care AG & Co. KGaA
  • 13.8. Haolang Technology (Foshan) Limited Co., Ltd.
  • 13.9. SCW Medicath Ltd
  • 13.10. Vygon

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us